Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-17-000033

Options or other derivatives

  • Director acquired 12,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Peterson Kristine · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-09-11 Grant or award : show line 1 in the form Stock Option (right to buy) +12,500 $42.61 2027-09-11 12,500 12,500 D
Loading xslF345X03/edgar.xml…